Joon Oh Park - Publications, H-index & Citations

Joon Oh Park

Sungkyunkwan University School of Medicine

74H指数

567论文数

3.1W被引数

收录论文 160

发表时间

Liquid biopsy for early detection of pancreatic ductal adenocarcinoma 液体活检用于胰腺导管腺癌的早期检测

Nature Medicine

IF50

2026-09-16

PREAI

Caiming Xu; Alessandro Mannucci; Haiyong Han; Ruben M. Munoz; Derek Cridebring; Sourat Darabi; Yuji Toiyama; Yoshinaga Okugawa; Gagandeep Singh; Mustafa Raoof; Joon Oh Park; James Lin; Gregory Idos; Michael J. Demeure; Erkut Borazanci; Douglas B. Evans; Susan Tsai; Eunsung Jun; Carlos Becerra; Scott A. Celinski; Laleh Melstrom; Vincent Chung; Guixin Zhang; Dong Shang; David L. Bartlett; Mitsuro Kanda; Song Cheol Kim; Valsamo Anagnastou; Giulia Martina Cavestro; John S. Bolton; Ali H. Zaidi; Daniel Von Hoff; Ajay Goel

Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors Beamion PANTUMOR-1: Zongertinib二线临床试验的试验依据与设计，用于HER2过表达/扩增或HER2突变的实体瘤

Future Oncology

IF2.6

2026-03-04

PREAI

Alison M. Schram; John J. Park; Antoine Italiano; Shigehisa Kitano; Ye Guo; Jin Li; Philippe L. Bedard; Cedric van Marcke; Ryo Ko; Lukas Lunger; Daniel M. Klotz; Jo Hussain; Daniela Maier; Damijan Erzen; David Planchard; Hans Prenen; Timothy D. Clay; Joon O. Park; Hyung-Don Kim; Alberto Hernando-Calvo; Yuta Maruki; Mariano Ponz-Sarvise; Ecaterina Dumbrava

Increased Risk of Young-Onset Pancreatic Cancer Among Adults Aged 20-39 Years with Overweight or Obesity, but Not Underweight: A Nationwide Cohort Study 超重或肥胖但非体重过轻的20-39岁成年人中早发性胰腺癌风险增加：一项全国性队列研究

European Journal of Cancer

IF7.1

2025-11-14

PREAI

Hyun-Jin Kim; Joo-Hyun Park; Jung Yong Hong; Kyungdo Han; Jay J. Shen; Joon Oh Park; Young Suk Park; Ho Yeong Lim

Clinical Outcomes and Prognostic Factors in Cerebral Abscess: Hyperglycemia as a Predictor of the Need for Prolonged Antibiotic Therapy 脑脓肿的临床结局与预后因素：高血糖作为需要延长抗生素治疗时间的预测指标

MEDICAL SCIENCE MONITOR

IF2.1

2025-10-18

PREAI

Park, Joon O.; Lee, Seongwoo; Kim, Jang Hun; Park, Dong-Hyuk; Kang, Shin-Hyuk; Park, Kyung-Jae

Epidermal Growth Factor Receptor Aberrations Identified by Next-Generation Sequencing in Patients with Metastatic Cancers 通过下一代测序在转移性癌症患者中鉴定的表皮生长因子受体异常

CANCER RESEARCH AND TREATMENT

IF3.8

2025-10-01

OAAI

Shin, Minkyue; Choi, Dae-Ho; Jung, Jaeyun; Kim, Deok Geun; An, Minae; Lim, Sung Hee; Kim, Seung Tae; Hong, Jung Yong; Park, Se Hoon; Park, Joon Oh; Kim, Kyoung-Mee; Lee, Jeeyun

Prevalence and clinical implications of PIK3CA aberrations across cancer types: A real-world next-generation sequencing approach PIK3CA异常在不同癌症类型中的流行率及临床意义：一种真实世界下一代测序方法

CANCER GENETICS

IF2.1

2025-09-01

PREAI

Kim, Junkyu; Jang, Hye-Lim; Hong, Jung Young; Kim, Seung Tae; Park, Se Hoon; Park, Joon Oh; Kim, Kyoung-Mee; Kim, Deok geun; Lee, Jeeyun; Lim, Sung Hee

Prediabetes Remission and the Subsequent Risk of Pancreatic Cancer: A Nationwide Cohort Study 糖尿病前期缓解与后续胰腺癌风险：一项全国性队列研究

American Journal of Preventive Medicine

IF4.5

2025-07-14

PREAI

Joo-Hyun Park; Jung Yong Hong; Kyungdo Han; Jay J. Shen; Minsuk Kwon; Young Suk Park; Joon Oh Park; Ho Yeong Lim

Immune-mediated adverse events in the randomized phase 3 TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer 度伐利尤单抗联合吉西他滨和顺铂治疗晚期胆道癌的随机III期TOPAZ-1研究中免疫介导的不良事件

ONCOLOGIST

IF4.2

2025-07-01

OAAI

Antonuzzo, Lorenzo; Takahashi, Hidenori; Park, Joon Oh; Sookprasert, Aumkhae; Gillmore, Roopinder; Yang, Sheng-Shun; Cundom, Juan; Petrova, Mila; Vaccaro, Gina; Holmblad, Marielle; Zotkiewicz, Magdalena; Wang, Julie; Rokutanda, Nana; Oh, Do-Youn

Prediabetes persistence or remission and subsequent risk of gallbladder cancer: A nationwide cohort study

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-12-01

PREAI

Park, Joo-Hyun; Hong, Jung Yong; Han, Kyungdo; Park, Young Suk; Park, Joon Oh; Lim, Ho Yeong; Shen, Jay J.

Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE

IF9.1

2024-11-23

OAAI

Min, Ji Hye; Yu, Jeong Il; Kim, Seong Hyun; Kim, Young Kon; Kim, Kangpyo; Park, Hee Chul; Park, Joon Oh; Hong, Jung Yong; Lee, Kyu Taek; Lee, Kwang Hyuck; Lee, Jong Kyun; Park, Joo Kyung; Choi, Jin Ho; Heo, Jin Seok; Han, In Woong; Kim, Hongbeom; Shin, Sang Hyun; Yoon, So Jung; Woo, Sook-young

Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial

BMC CANCER

IF3.4

2024-08-13

OAAI

Park, Joon Oh; Feng, Yin-Hsun; Su, Wu-Chou; Oh, Do-Youn; Keam, Bhumsuk; Shen, Lin; Kim, Sang-We; Liu, Xiufeng; Liao, Huimin; Qing, Min; Zhang, Chong; Qian, Jiaqi; Tang, Xiaodan; Li, Peng; Triantos, Spyros; Sweiti, Hussein

Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1) : updated overall survival from a randomised phase 3 study

LANCET GASTROENTEROLOGY & HEPATOLOGY

IF38.6

2024-08-01

PREAI

Oh, Do-Youn; He, Aiwu Ruth; Bouattour, Mohamed; Okusaka, Takuji; Qin, Shukui; Chen, Li-Tzong; Kitano, Masayuki; Lee, Choong-kun; Kim, Jin Won; Chen, Ming -Huang; Suksombooncharoen, Thatthan; Ikeda, Masafumi; Lee, Myung Ah; Chen, Jen-Shi; Potemski, Piotr; Burris, Howard A.; Ostwal, Vikas; Tanasanvimon, Suebpong; Morizane, Chigusa; Zaucha, Renata E.; Mcnamara, Mairead G.; Avallone, Antonio; Cundom, Juan E.; Breder, Valeriy; Tan, Benjamin; Shimizu, Satoshi; Tougeron, David; Evesque, Ludovic; Petrova, Mila; Zhen, David B.; Gillmore, Roopinder; Gupta, Vineet Govinda; Dayyani, Farshid; Park, Joon Oh; Buchschacher Jr, Gary L.; Rey, Felipe; Kim, Hyosung; Wang, Julie; Morgan, Claire; Rokutanda, Nana; Zotkiewicz, Magdalena; Vogel, Arndt; Valle, Juan W.

An exosome-based liquid biopsy signature for therapeutic response prediction in metastatic gastric cancer

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2024-07-19

OAAI

Okuno, Keisuke; Watanabe, Shuichi; Hur, Hoon; Lee, Jeeyun; Park, Joon Oh; Tokunaga, Masanori; Tanabe, Minoru; Kinugasa, Yusuke; Goel, Ajay

Bintrafusp alfa and chemotherapy as first-line treatment in biliary tract cancer: A randomized phase 2/3 trial

HEPATOLOGY

IF15.8

2024-06-14

OAAI

Oh, Do-Youn; Ikeda, Masafumi; Lee, Choong-kun; Rojas, Carlos; Hsu, Chih-Hung; Kim, Jin Won; Shen, Lin; Furuse, Junji; Park, Joon Oh; Borad, Mitesh; de Braud, Filippo; Bridgewater, John; Lee, Sunyoung S.; Moehler, Markus; Audhuy, Francois; Osada, Motonobu; Sato, Masashi; Yoo, Changhoon

Prevalence of RAF1 Aberrations in Metastatic Cancer Patients: Real-World Data

BIOMEDICINES

IF3.9

2023-12-09

OAAI

Lim, Sung Hee; Jung, Jaeyun; Hong, Jung Young; Kim, Seung Tae; Park, Se Hoon; Park, Joon Oh; Kim, Kyoung-Mee; Lee, Jeeyun

Clinical activity of lirafugratinib (RLY-4008), a highly selective FGFR2 inhibitor, in patients with advanced FGFR2-altered solid tumors: The ReFocus study

MOLECULAR CANCER THERAPEUTICS

IF5.5

2023-12-01

PREAI

Schram, Alison M.; Subbiah, Vivek; Liao, Chih-Yi (Andy); Moreno, Victor; Desamparados, Roda; Ponz-Sarvise, Mariano; Dotan, Efrat; Cassier, Philippe Alexandre; Moreno, Irene; Varkaris, Andreas; Kim, Richard D.; Garralda, Elena; Opdam, Frans; Tai, David; Italiano, Antoine; Oh, Do-Youn; Goyal, Lipika; Fontana, Elise; Liu, Jia; Boukovala, Myrto; Ghiringelli, Francois; Borad, Mitesh J.; Babiker, Hani; Jin, Zhaohui; Millward, Michael; Yachnin, Jeffrey; Kamath, Suneel Deepak; Coward, Jermaine M.; Yoo, Changhoon; Kelley, Robin Kate; Sahai, Vaibhav; Bridgewater, John; Springfield, Christoph; Florou, Vaia; El-Khoueiry, Anthony; Eskens, Ferry; Lin, Bruce; Paulson, Scott; Curigliano, Giuseppe; Murphy, Meredith; Deary, Alicia; Ricard, Fabien; Jen, Kai Yu; Ramirez, Florence (Tianhui); Blakesley, Rick E.; Schmidt-Kittler, Oleg; Mar, Brenton G.; Park, Joon Oh; Hollebecque, Antoine

Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer

SCIENCE ADVANCES

IF12.5

2023-11-24

OAAI

Hyung, Sujin; Ko, Jihoon; Heo, You Jeong; Blum, Steven M.; Kim, Seung Tae; Park, Se Hoon; Park, Joon Oh; Kang, Won Ki; Lim, Ho Yeong; Klempner, Samuel J.; Lee, Jeeyun

Smoking Cessation and Pancreatic Cancer Risk in Individuals With Prediabetes and Diabetes: A Nationwide Cohort Study

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2023-11-01

OAAI

Park, Joo-Hyun; Hong, Jung Yong; Shen, Jay J.; Han, Kyungdo; Park, Young Suk; Park, Joon Oh

Asian subgroup analysis of the phase III LEAP-017 trial of lenvatinib plus pembrolizumab vs standard-of-care in previously treated metastatic colorectal cancer (mCRC)

ANNALS OF ONCOLOGY

IF65.4

2023-11-01

PREAI

Xu, R-H.; Chen, Z.; Teng, H-W.; Pan, H.; Zhong, H.; Takashima, A.; Yang, T-S.; Yeh, Y-M.; Deng, Y.; Kim, T. W.; Kim, T-Y.; Park, J. O.; Lee, M. A.; Lee, S.; Yeh, K-H.; Yoshino, T.; Fu, R.; Jain, R.; Adelberg, D. E.; Kawazoe, A.

Neoadjuvant durvalumab plus gemcitabine and cisplatin (D plus GemCis) versus gemcis alone for localized biliary tract cancer (BTC): Results of a randomized, multicenter, open-label, phase II trial (DEBATE)

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Yoo, C.; Park, J. O.; Kim, K-P.; Hyung, J.; Ryoo, B-Y.; Hong, J. Y.; Shin, S. H.; Song, T. J.; Oh, D.; Lee, W.; Kwak, B. J.; Lee, J. H.; Hwang, D. W.

研究方向